Rhee, Ina P.,Kim, Jeong,Huseni, Mahrukh,Stefanich, Eric,Sukumaran, Sid,Li, Chi-Chung
申请号：
AU2016274584
公开号：
AU2016274584A1
申请日:
2016.06.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention provides methods of treating or delaying progression of cancer in an individual comprising administering to the individual an anti-human OX40 agonist antibody and an anti-PDL1 antibody. In some embodiments, the anti-human OX40 agonist antibody is administered in a dose selected from about 0.8mg, about 3.2mg, about 12mg, about 40mg, about 80mg, about 130mg, about 160mg, about 300mg, about 320mg, about 400mg, about 600mg, and about 1200mg, and the anti-PDL1 antibody is administered at a dose of about 800mg or about 1200mg.
